Non-opioid Pain Treatment: Global Markets to 2024HomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Non-opioid Pain Treatment: Global Markets to 2024GlobeNewswireJanuary 8, 2020ReblogShareTweetShareDublin, Jan. 08, 2020 (GLOBE NEWSWIRE) -- The "Non-opioid Pain Treatment: Global Markets to 2024" report has been added to ResearchAndMarkets.com's offering.This report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management.The geographical scope of this study is global. This study addresses acute versus chronic pain, treatments and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts and competitive analyses.The report identifies five general product segments for Non-opioid treatment of pain:Medical cannabis treatmentsCapsaicin-derived treatmentsMenthol-containing treatmentsOmega 3 fatty acid-containing treatmentsBotulinum toxinsWithin the segment, several sub-segments are discussed as they pertain to each product segment; diseases or disorders are the basis for these sub-segments, including:ArthritisCancer-brain, breast, colorectal, leukemia/lymphoma, melanoma, prostate, othersDentalEpilepsyFibromyalgiaMigraineMultiple sclerosisSurgicalEach market segment provides detailed information based on product categories, product use, current market value and forecasts.Report ScopeAn overview of the global market for Non-opioid pain treatmentsAnalyses of global market trends, with data from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024Description of products included in this market, and a detailed analysis of the markets and market opportunitiesInformation on significant products categories, issues and trends, market influences, regulatory issues and other information affecting the pain management industryBriefing about major drivers and regional dynamics of the market and current trends within the industryComprehensive profiles of major vendors in the market, including Allergan, Canopy Growth Corp, Medical Marijuana, Panag Pharma, and TilrayKey Topics Covered
Chapter 1 IntroductionStudy Goals and ObjectivesReasons for Doing This StudyScope of ReportInformation SourcesMethodologyGeographic BreakdownChapter 2 Summary and HighlightsMarket OverviewDrivers and RestraintsChapter 3 Market Overview and BackgroundDefinition of Pain and NociceptionPainNociceptionHistory of Pain and Pain TreatmentTypes of PainAcute PainChronic PainPhysiological Pain ClassificationsHow Pain is DiagnosedHow Pain is TreatedOpioid vs. Non-opioid Pain ControlOpioids, also Known as Narcotic AnalgesicsFull and Partial AgonistsAgonist-AntagonistsRisk and Complications in Opioid Pain TreatmentAddiction and AbuseChallenges of Breakthrough Pain ControlAlternative Methods of Pain ManagementAlternative Non-opioid Therapies for Treating PainMedical CannabisCapsaicin-derived CompoundMenthol-containing CompoundOmega 3 Fatty Acid-containing SupplementsBotulinum Toxins (OnabotulinumtoxinA/RimabotulinumtoxinB)OthersGrowing Trend in Cannabis Treatment for PainAdoption of Medical Cannabis: A Global AnalysisLaws and Legalization TrendsClaims in EffectivenessPotency and Validation Testing TrendsHospice CareAccess to Palliative Care Around the WorldAssessing the Need for Palliative CareMarket Influences and Indicators of GrowthDemographic OverviewIncidence and Prevalence of Conditions with Pain SymptomsChapter 4 Market Breakdown by Product SegmentOverviewMedical CannabisCapsaicin-derived TherapiesMenthol-containing TherapiesOmega-3 Fatty Acid-containing TherapiesBotulinum Toxin TreatmentsChapter 5 Market Breakdown by Therapeutic ApplicationOverviewAlternative Non-opioid Cancer Pain TreatmentAlternative Non-opioid Neuropathic Pain TreatmentAlternative Non-opioid Orthopedic/Musculoskeletal Pain TreatmentsOther Alternative Non-Opioid Pain TreatmentsChapter 6 Market Breakdown by RegionOverviewRegional GroupingsNorth AmericaNorth America: Pioneer in the Medicinal Cannabis IndustryCanadaUnited StatesEMEAFranceGermanyItalyRussiaSpainUnited KingdomAsia-PacificAustralia/New ZealandChinaJapanLatin AmericaArgentinaBrazilMexicoChapter 7 Patent AnalysisPatent Analysis OverviewNon-opioid Pain Relief CategoriesMedical CannabisTechnologiesCannabis Patent Review by YearPatent Review by CompanyPatent Review by AssigneeChapter 8 Company ProfilesAllergan PLCAphria Inc.AuroraBedrocanCanopy Growth Corp.Cara TherapeuticsCentrexion TherapeuticsCHT MedicalCronos GroupGW PharmaceuticalsMedical Marijuana Inc.Medropharm GmbHPanag Pharma Inc.TilrayUS Worldmeds LLCVanwayFor more information about this report visit https://www.researchandmarkets.com/r/26u7azResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextAsian markets continue to slump, as Nikkei enters correction territoryMarketWatchOil’s Worst Week Since 2011 Puts Pressure on OPEC+ to RespondBloombergItalian PM Conte says EU should look at competition rules to build European championsReutersNorway's sovereign wealth fund gains £140bn in one year - £26,400 for every citizenThe IndependentBuffett Indicator Signals Warning to Global MarketsGuruFocus.comBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoMost face masks won’t protect you from the coronavirusYahoo Finance'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloomberg